Three patients (one co-ultraPEAlut and two placebo) had evidence of a genetic form of FTD (C9orf72 mutation), whereas no mutation was identified in the GRN, MAPT or TARDBP genes. This evidence concerns the gene MAPT and frontotemporal dementia.